Testing effectiveness (Phase 2)Active Not RecruitingNCT05501054
What this trial is testing
Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.
Who this might be right for
Renal Cell Carcinoma
M.D. Anderson Cancer Center 50